AMAG Pursues Expanded Feraheme Strategy Through Lumara Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech is acquiring privately held Lumara and its women’s health product Makena in hopes of using the salesforce once it expands the indication for its I.V. iron product Feraheme into that market.